The pathogenesis of constipation

Journal of Supportive Oncology

Volumn 4, Issue 5, 2006, Pages 213-218

  Sykes, Nigel P ^a,b  

^a ST CHRISTOPHER S HOSPICE   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTINEOPLASTIC AGENT; CALCIUM; CARBOPLATIN; HYDROMORPHONE; INTERLEUKIN 1BETA; LAXATIVE; METHADONE; MORPHINE; NEUROLEPTIC AGENT; OCTREOTIDE; ONDANSETRON; OPIATE; PEPTIDE YY; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR NECROSIS FACTOR ALPHA; VINCA ALKALOID;

ANOREXIA; BIOCHEMISTRY; CANCER PAIN; CANCER PATIENT; CONSTIPATION; DIETARY FIBER; DIETARY INTAKE; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; EXERCISE; FLUID FLOW; FLUID INTAKE; FOOD INTAKE; HUMAN; HYPERCALCEMIA; INTESTINE FUNCTION; INTESTINE INNERVATION; INTESTINE MOTILITY; INTESTINE OBSTRUCTION; INTESTINE TRANSIT TIME; LUNG SMALL CELL CANCER; NERVE INJURY; NEUROLOGIC DISEASE; PARANEOPLASTIC SYNDROME; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; REVIEW;

AGE FACTORS; CONSTIPATION; DIET; EXERCISE; GASTROINTESTINAL MOTILITY; HUMANS; INTESTINES; NEOPLASMS; RISK FACTORS;

EID: 33646771321     PISSN: 15446794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Dunlop GM. A study of the relative frequency and importance of gastrointestinal symptoms and weakness in patients with far advanced cancer: student paper. Palliat Med 1989;4:37-44.
2. Holmes S. Use of a modified symptom distress scale in assessment of the cancer patient. Int J Nurs Stud 1989;26:69-79.
3. Sykes NP. Methods of assessment of bowel function in patients with advanced cancer. Palliat Med 1990;4:287-292.
4. Kunze WA, Furness JB. The enteric nervous system and regulation of intestinal motility. Annu Rev Physiol 1999;61:117-142.
5. Gershon MD. Review article:serotonin receptors and transporters - roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 2004;20(suppl 7):3-14.
6. Winge K, Rasmussen D, Werdelin LM. Constipation in neurological diseases. J Neurol Neurosurg Psychiatry 2003;74:13-19.
7. Bassotti G, de Roberto G, Castellani D, Sediari L, Morelli A. Normal aspects of colorectal motility and abnormalities in slow transit constipation. World J Gastroenterol 2005;11:2691-2696.
8. Cooke HJ, Sidhu M, Wang YZ. Activation of 5-HT1P receptors on submucosal afferents subsequently triggers VIP neurons and chloride secretion in the guinea-pig colon. J Auton Nerv Syst 1997;66:105-110.
9. Banks MR, Farthing MJ. Fluid and electrolyte transport in the small intestine. Curr Opin Gastroenterol 2002;18:176-181.
10. Baines M, Oliver DJ, Carter RL. Mechanical management of intestinal obstruction in patients with advanced malignant disease: a clinical and pathological study. Lancet 1985;2:990-993.
11. Carter RL, Pittam MR, Tanner NS. Pain and dysphagia in patients with squamous carcinomas of the head and neck: the role of perineural spread. J R Soc Med 1982;75:598-606.
12. Jun S, Dimyan M, Jones KD, Ladabaum U. Obstipation as a paraneoplastic presentation of small cell lung cancer: case report and literature review. Neurogastroenterol Motil 2005;17:16-22.
13. Ahmed MN, Carpenter S. Autonomic neuropathy and carcinoma of the lung. Can Med Assoc J 1975;113:410-412.
14. Walsh D, Nelson KA. Autonomic nervous system dysfunction in advanced cancer. Support Care Cancer 2002;10:523-528.
15. Graus F, Cordon-Cardo C, Posner JB. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 1985;35:538-543.
16. Utsumi N, Hayasaka T, Motoyama T. Ovarian carcinoid exhibiting double function. Pathol Int 2003;53:191-194.
17. Sorhaug S, Steinshamn SL, Waldum HL. Octreotide treatment for paraneoplastic intestinal pseudo-obstruction complicating SCLC. Lung Cancer 2005;48:137-140.
18. Nilsen EM, Johansen FE, Jahnsen FL, et al. Cytokine profiles of cultured microvascular endothelial cells from the human intestine. Gut 1998;42:635-642.
19. Bode H, Schmitz H, Fromm M, Scholz P, Riecken EO, Schulzke JD. IL-1beta and TNF-alpha, but not IFN-alpha, IFN-gamma, IL-6 or IL-8, are secretory mediators in human distal colon. Cytokine 1998;10:457-465.
20. Van Assche G, Collins SM. Leukemia inhibitory factor mediates cytokine-induced suppression of myenteric neurotransmitter release from rat intestine. Gastroenterology 1996;111:674-681.
21. Sales ME, Sterin BL, de Bracco MM, Borda ES. Tyrosine kinase regulatory action on ileal muscarinic effects of IFN-gamma. J Interferon Cytokine Res 1999;19:375-382.
22. Plattner V, Leray V, Leclair MD, Aube AC, Cherbut C, Galmiche JP. Interleukin-8 increases acetylcholine response of rat intestinal segments. Aliment Pharmacol Ther 2001;15:1227-1232.
23. Sykes NP. The relationship between opioid use and laxative use in terminally ill cancer patients. Palliat Med 1998;12:375-382.
24. Wood JD, Galligan JJ. Function of opioids in the enteric nervous system. Neurogastroenterol Motil 2004;16(suppl 2):17-28.
25. Bannister JJ, Davison P, Timms JM, Gibbons C, Read NW. Effect of stool size and consistency on defecation. Gut 1987;28:1246-1250.
26. Radbruch L, Sabatowski R, Loick G, et al. Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine. Palliat Med 2000;14:111-119.
27. Daeninck PJ, Bruera E. Reduction in constipation and laxative requirements following opioid rotation to methadone: a report of four cases. J Pain Symptom Manage 1999;18:303-309.
28. Mancini IL, Hanson J, Neumann CM, Bruera ED. Opioid type and other clinical predictors of laxative dose in advanced cancer patients: a retrospective study. J Palliat Med 2000;3:49-56.
29. Smith S. Evidence-based management of constipation in the oncology patient. Eur J Oncol Nurs 2001;5:18-25.
30. Richmond JP, Wright ME. Review of the literature on constipation to enable development of a constipation risk assessment scale. Clin Eff Nurs 2004;8:11-25.
31. Connell AM, Hilton C, Irvine G, Lennard-Jones JE, Misiewicz JJ. Variation of bowel habit in two population samples. Br Med J 1965;5470:1095-1099.
32. Ashraf W, Park F, Lof J, Quigley EM. An examination of the reliability of reported stool frequency in the diagnosis of idiopathic constipation. Am J Gastroenterol 1996;91:26-32.
33. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999;45(suppl 2):1143-1147.
34. Gomes OA, de Souza RR, Liberti EA. A preliminary investigation of the effects of aging on the nerve cell number in the myenteric ganglia of the human colon. Gerontology 1997;43:210-217.
35. Hanani M, Fellig Y, Udassin R, Freund HR. Age-related changes in the morphology of the myenteric plexus of the human colon. Auton Neurosci 2004;113:71-78.
36. Read NW, Abouzekry I, Read MG, Howell P, Ottewell D, Donnelly TC. Anorectal function in elderly patients with fecal impaction. Gastroenterology 1985;89:959-966.
37. Asher R. The dangers of going to bed. Br Med J 1947;2:967-968.
38. Cordain L, Latin RW, Behnke JJ. The effects of an aerobic running program on bowel transit time. J Sports Med Phys Fitness 1986;26:101-104.
39. Holdstock DJ, Misiewicz JJ, Smith T, Rowlands EN. Propulsion (mass movements) in the human colon and its relationship to meals and somatic activity. Gut 1970;11:91-99.
40. Sandler RS, Jordan MC, Shelton BJ. Demographic and dietary determinants of constipation in the US population. Am J Public Health 1990;80:185-189.
41. Tuteja AK, Talley NJ, Joos SK, Woehl JV, Hickam DH. Is constipation associated with decreased physical activity in normally active subjects? Am J Gastroenterol 2005;100:124-129.
42. Addington-Hall J, McCarthy M. Dying from cancer: results of a national population-based investigation. Palliat Med 1995;9:295-305.
43. Muller-Lissner SA. Effect of wheat bran on weight of stool and gastrointestinal transit time: a meta analysis. Br Med J (Clin Res Ed) 1988;296:615-617.
44. Mumford SP. Can high fibre diets improve the bowel function in patients on radiotherapy ward? In: Twycross RG, Lack SA, eds. Control of Alimentary Symptoms in Far Advanced Cancer. Edinburgh: Churchill Livingstone; 1986:183.
45. Ouellet LL, Turner TR, Pond S. McLaughlin H, Knorr S. Dietary fiber and laxation in postop orthopedic patients. Clin Nurs Res 1996;5:428-440.
46. Waud SP. Fecal impaction due to a hygroscopic gum laxative. Am J Dig Dis 1940;7:297-298.
47. Anti M, Pignataro G, Armuzzi A, et al. Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation. Hepatogastroenterology 1998;45:727-732.
48. DeSchepper HU, Cremonuni F, Park MI, Camilleri M. Opioids and the gut: pharmacology and current clinical experience. Neurogastroenterol Motil 2004;16:383-394.
49. Kreek MJ, Schaefer RA, Hahn EF, Fishman J. Naloxone, a specific opioid antagonist, reverses chronic idiopathic constipation. Lancet 1983;1:261-262.